CXCR4 WHIM‐like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88L265P‐directed survival signalling in Waldenström macroglobulinaemia cells

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|168|5|701-707

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.168, Iss.5, 2015-03, pp. : 701-707

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 795-803

John Wiley & Sons Inc

Access to resources Recommend Favorite

The BCL2 antagonist ABT‐199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4Wild‐type and CXCR4WHIM mutated Waldenstrom macroglobulinaemia cells

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 1, 2015-07 ,pp. : 134-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 578-581

John Wiley & Sons Inc

Access to resources Recommend Favorite

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 187-194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 2, 2015-07 ,pp. : 285-287

John Wiley & Sons Inc

Access to resources Recommend Favorite